In summary, our data identified a crucial oncogenic role of Mig-6 in the survival of EGFR-TKI-resistant lung adenocarcinoma and we suggest targeting Mig-6 to overcome EGFR-TKI resistance in lung cancer (Fig. 7). This evidence concerns the gene ERRFI1 and lung carcinoma.